Pegylated interferon-alfa-2A plus adefovir combination therapy is superior to pegylated interferon-alfa-2A alone or adefovir monotherapy in reducing HBsAg levels in hdvcoinfected patients with low HBV viremia

Author
Wedemeyer, Heiner
Manns, Michael P.
Dalekos, George
Bock, Thomas
Zeuzem, Stefan
Drebber, Ulrike
Cakaloglu, Ya
Degertekin, Ha
Gurel, Sa
Zachou, Kalliopi
Yurdaydin, Cihan
Erhardt, Alexander
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/120155
Collections